Doximity, Inc. (DOCS)
| Market Cap | 9.32B |
| Revenue (ttm) | 516.85M |
| Net Income (ttm) | 174.11M |
| Shares Out | 186.69M |
| EPS (ttm) | 0.87 |
| PE Ratio | 57.10 |
| Forward PE | 43.95 |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 2,337,046 |
| Open | 51.36 |
| Previous Close | 51.53 |
| Day's Range | 49.66 - 51.58 |
| 52-Week Range | 22.96 - 61.75 |
| Beta | 1.30 |
| Analysts | Buy |
| Price Target | 50.43 (+1.06%) |
| Earnings Date | Nov 7, 2024 |
About DOCS
Doximity, Inc. operates a cloud-based digital platform for medical professionals in the United States. The company’s platform provides its members with digital tools built for medicine, that enables its members to collaborate with colleagues, stay up to date with the latest medical news and research, manage their careers and on-call schedules, streamline documentation and administrative paperwork, and conduct virtual patient visits. It primarily serves physicians, nurse practitioners, physician assistants, medical students, pharmaceutical manuf... [Read more]
Financial Performance
In 2023, Doximity's revenue was $475.42 million, an increase of 13.45% compared to the previous year's $419.05 million. Earnings were $147.58 million, an increase of 30.81%.
Financial StatementsAnalyst Forecast
According to 14 analysts, the average rating for DOCS stock is "Buy." The 12-month stock price forecast is $50.43, which is an increase of 1.06% from the latest price.
News
Doximity Q2 Earnings: Positioning Is Paying Off
I rate Doximity a buy with a price target of $65, reflecting a 24% upside due to strong Q2 earnings and favorable industry trends. Doximity's Q2 earnings showed impressive revenue growth, margin expan...
Why Doximity Stock is Set to Open at Highest Point in Over 2 Years Friday
Doximity (DOCS) shares jumped nearly 40% in premarket trading Friday after the medical tech company's earnings and outlook came in above what analysts expected.
Doximity Stock Soars 42% Toward Best Day Ever. It's Not the Only Record.
The online medical platform reported quarterly revenue of $136.8 million and earnings of 30 cents a share, beating analysts expectations.
Doximity, Inc. (DOCS) Q2 2025 Earnings Call Transcript
Doximity, Inc. (NYSE:DOCS) Q2 2025 Earnings Conference Call November 7, 2024 5:00 PM ET Company Participants Perry Gold - Vice President of Investor Relations Jeff Tangney - Co-Founder and CEO Anna B...
Doximity Announces Fiscal 2025 Second Quarter Financial Results
SAN FRANCISCO--(BUSINESS WIRE)--Doximity, Inc. (NYSE: DOCS), the leading digital platform for U.S. medical professionals, today announced results of its fiscal 2025 second quarter ended September 30, ...
Doximity to Present at the Jefferies London Healthcare Conference
SAN FRANCISCO--(BUSINESS WIRE)--Doximity, Inc. (NYSE: DOCS), the leading digital platform for U.S. medical professionals, today announced that Nate Gross, co-founder and chief strategy officer, and An...
Doximity to Release Fiscal 2025 Second Quarter Results on November 7, 2024
SAN FRANCISCO--(BUSINESS WIRE)--Doximity, Inc. (NYSE:DOCS), the leading digital platform for U.S. medical professionals, today announced it will report financial results for its fiscal second quarter ...
Overlooked Stock: DOCS
Doximity (DOCS) is trading near its 52-week high after getting an upgrade from Barclays. George Tsilis talks about why the "LinkedIn for physicians" can be gaining investor interest.
DOXIMITY INVESTOR REMINDER: Scott+Scott Attorneys at Law LLP Investigates Doximity, Inc.'s Directors and Officers for Breach of Fiduciary Duties – DOCS
NEW YORK--(BUSINESS WIRE)--Scott+Scott Attorneys at Law LLP (“Scott+Scott”), an international securities and consumer rights litigation firm, is investigating whether the leadership of Doximity, Inc. ...
Top 4 Health Care Stocks That May Keep You Up At Night
As of Sept. 24, 2024, four stocks in the health care sector could be flashing a real warning to investors who value momentum as a key criteria in their trading decisions.
Reconsidering Doximity Shares: Should Investors Bet On A Sustained Revenue Growth Inflection
Doximity's guidance in no way reflects the positive tea leaves management discussed during the conference call. Doximity reported better than expected Q1 results with revenues of $127 million and adju...
Doximity: Q1 Earnings Mark A Possible Turnaround For The Company (Rating Upgrade)
Doximity reported strong Q1 FY25 earnings with revenue and Adjusted EBITDA growing 17% and 41% YoY respectively, beating estimates. It saw a 16% increase in customer count in its $500K+ Subscription r...
Doximity Stock Jumps 31%. Here's Why.
The medical platform's quarterly result beat expectations on both top and bottom lines, and is also leveraging AI to appeal to customers.
Doximity, Inc. (DOCS) Q1 2025 Earnings Call Transcript
Start Time: 17:00 January 1, 0000 5:50 PM ET Doximity, Inc. (NYSE:DOCS) Q1 2025 Earnings Conference Call August 08, 2024, 17:00 PM ET Company Participants Jeff Tangney - Co-founder and CEO Nate Gross...
Doximity Announces Fiscal 2025 First Quarter Financial Results
SAN FRANCISCO--(BUSINESS WIRE)--Doximity, Inc. (NYSE: DOCS), the leading digital platform for U.S. medical professionals, today announced results of its fiscal 2025 first quarter ended June 30, 2024. ...
Doximity to Release Fiscal 2025 First Quarter Results on August 8, 2024
SAN FRANCISCO--(BUSINESS WIRE)--Doximity, Inc. (NYSE:DOCS), the leading digital platform for U.S. medical professionals, today announced it will report financial results for its fiscal first quarter e...
DOCS Investors Have Opportunity to Join Doximity, Inc. Securities Fraud Investigation with the Schall Law Firm
LOS ANGELES--(BUSINESS WIRE)--DOCS Investors Have Opportunity to Join Doximity, Inc. Securities Fraud Investigation with the Schall Law Firm.
Rosen Law Firm Urges Doximity, Inc. (DOCS) Stockholders with Large Losses to Contact the Firm for Information About Their Rights
NEW YORK--(BUSINESS WIRE)--Rosen Law Firm, a global investor rights law firm, reminds purchasers of common stock of Doximity, Inc. (NYSE: DOCS) between February 9, 2022 and April 1, 2024. Doximity des...
INVESTOR DEADLINE APPROACHING: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Doximity
NEW YORK, June 12, 2024 (GLOBE NEWSWIRE) -- Faruqi & Faruqi, LLP, a leading national securities law firm, is investigating potential claims against Doximity, Inc. (“Doximity” or the “Company”) (NYSE: ...
The Schall Law Firm Urges Investors Who Have Suffered Losses With Doximity, Inc. To Make Contact. Please Keep In Mind The Deadline For This Matter
LOS ANGELES, CA / ACCESSWIRE / June 11, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Doximity, Inc. ("Doximity" or "th...
The Schall Law Firm Encourages Investors Who Have Incurred Losses With Doximity, Inc. To Reach Out. Please Be Conscious Of The Time Limit In This Issue
LOS ANGELES, CA / ACCESSWIRE / June 9, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Doximity, Inc. ("Doximity" or "the...
The Schall Law Firm Urges Investors Who Have Suffered Losses In Doximity, Inc. To Make Contact. Please Be Mindful Of The Deadline For This Matter
LOS ANGELES, CA / ACCESSWIRE / June 8, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Doximity, Inc. ("Doximity" or "the...
The Schall Law Firm Encourages Investors Who Experienced Losses With Doximity, Inc. To Get In Touch. Please Remember The Deadline For This Issue
LOS ANGELES, CA / ACCESSWIRE / June 7, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Doximity, Inc. ("Doximity" or "the...
The Schall Law Firm Is Urging Investors Who Have Suffered Losses In Doximity, Inc. To Reach Out. Please Be Mindful Of The Deadline In This Matter
LOS ANGELES, CA / ACCESSWIRE / June 6, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Doximity, Inc. ("Doximity" or "the...
SHAREHOLDER ACTION REMINDER: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Doximity
NEW YORK , June 6, 2024 /PRNewswire/ -- Faruqi & Faruqi, LLP, a leading national securities law firm, is investigating potential claims against Doximity, Inc. ("Doximity" or the "Company") (NYSE: DOCS...